Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study
- 29 November 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 42 (3) , 315-322
- https://doi.org/10.1016/j.jhep.2004.11.025
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and CirrhosisNew England Journal of Medicine, 2000
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Association between reactive oxygen species and disease activity in chronic hepatitis CFree Radical Biology & Medicine, 1996
- Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitisPublished by Elsevier ,1995
- Epidemiology of Hepatitis C in the WestSeminars in Liver Disease, 1995
- Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis.The Journal of Experimental Medicine, 1994
- Serum levels of cytokines in chronic liver diseasesGastroenterology, 1992